AI HEALTH TECH(01715): Focus on major health, digital medical and health care services.

AI HEALTH TECH (01715) announcement, with the global population structure change and the increase in health awareness, the big health industry is ushering in unprecedented development opportunities. Especially in China, with the acceleration of the aging process and the widespread application of digital technology, the big health market represented by the "silver economy" continues to expand. In order to actively respond to the national "Healthy China" strategic direction, the Group, on the premise of consolidating all existing businesses, will focus on big health, digital medical care, and rehabilitation services based on existing health-related businesses, and build a "prevention-diagnosis-treatment-medication-rehabilitation-care" full-cycle health service ecosystem, aiming to make greater contributions to the Group's revenue. 1. Using General Artificial Intelligence (AGI) technology and digital empowerment to enhance the health industry and create an intelligent health management platform The Group has recently established its wholly-owned subsidiary Shenzhen Cando Health Technology Co., Ltd. and formed a research and development team composed of professionals in software engineering, data science, and health management. The team will focus on health data analysis and intelligent services, and develop a one-stop health management platform that supports real-time monitoring of health data for all age groups and throughout the lifecycle by combining in-house R&D and third-party technology licensing. Leveraging General Artificial Intelligence (AGI), the platform aims to deliver healthy lifestyles and beliefs to users. The platform plans to integrate functions such as dynamic vital sign monitoring, intelligent risk assessment, personalized health interventions, and medication reminders, and will connect with medical institutions, rehabilitation care facilities, and home care scenarios. To continue advancing technology iteration and platform optimization, the Group plans to further increase investment in General Artificial Intelligence and big data systems in the health field over the next three years. It is expected that after the platform is officially launched, it will significantly increase the Group's revenue annually, gradually forming a profit model driven by both technology output and service subscription. 2. Layout of high-end medical care and rehabilitation industries, building a silver economy synergy system In response to the growing demand for high-quality rehabilitation care, the Group is actively expanding its business depth in the medical care and rehabilitation fields. As of now, the Group has signed strategic cooperation agreements with several enterprises such as State-owned Zhongkang (Guangxi) Health Industry Co., Ltd., and Anhui Eight Chongqing Qianli Technology Development Co., Ltd., and jointly established a joint venture company in Anhui to explore the development of biomedicine, rehabilitation nursing, health management, etc., in Greater China. The cooperation will be promoted in the form of setting up joint ventures, making full use of the resource advantages of all parties in research and development, production, channels, etc. The Group will rely on its distribution network in the Greater Bay Area of Guangdong, Hong Kong, and Macao and mainland cities to promote and sell related products in the market. According to the current plan, the related joint ventures are expected to bring positive cash flow to the Group by 2026. 3. Strengthening trade in health and personal care products, improving channel and supply chain layout Based on the research forecasts of institutions such as Frost & Sullivan, the scale of the Chinese health industry and the silver economy continues to grow, with huge potential in the elderly health and personal care product markets. In order to accurately grasp the demand in specific market segments, the Group will integrate its existing resource advantages, strengthen its presence in e-commerce channels (including Tmall, JD.com, Douyin, and Dewo, etc.), and gradually establish a product supply chain system covering online and offline platforms. Currently, the Group has reached initial cooperation intentions with multiple high-quality suppliers from mainland China, Hong Kong, Japan, South Korea, the United States, and the European Union, planning to introduce multi-category personal health care products. According to current market research and sales forecasts, this business segment is expected to bring stable revenue to the Group in the fourth quarter of 2025 and gradually form scale and a certain market share in 2026 and 2027. This business expansion is an important strategic move formulated by the Group based on market trends and its own resource advantages, aiming to build a complete business chain covering health management, rehabilitation services, and product trade through the dual-drive of "technology + health" and "product + service". In the future, the Group will continue to increase investment in digitization, General Artificial Intelligence, biotechnology, etc., to continuously improve comprehensive service capabilities and industry competitiveness. The Group firmly believes that the above layout will not only enrich the existing business structure and cultivate new profit growth points but will also create long-term sustainable value for shareholders and investors.